A. Poulsen

发表

Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women

C. Svarer, P. Fisher, G. Knudsen, 2020, Acta psychiatrica Scandinavica.

Evidence for a serotonergic subtype of major depressive disorder: A NeuroPharm-1 study.

C. Svarer, G. Knudsen, H. Eiberg, 2020, medRxiv.

P.849 Serotonin 4 receptor binding is positively associated with brain response to reward

B. Ozenne, P. Fisher, G. Knudsen, 2019, European Neuropsychopharmacology.

Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study

P. Fisher, G. Knudsen, M. Ganz, 2021, European Neuropsychopharmacology.

Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction.

C. Svarer, G. Knudsen, H. Eiberg, 2023, JAMA psychiatry.

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study

C. Svarer, G. Knudsen, V. Frokjaer, 2022, Translational Psychiatry.

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study

C. Svarer, G. Knudsen, V. Frokjaer, 2022, Frontiers in Endocrinology.

P.0692 Oral contraceptives and the serotonin 4 receptor in major depressive disorder: results from the NeuroPharm 1 study

C. Svarer, V. Frokjaer, B. Ozenne, 2021, European Neuropsychopharmacology.